NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 4I3X designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4I3X_NAD_A_501 | 97% | 21% | 0.052 | 0.975 | 1.38 | 1.81 | 7 | 14 | 4 | 0 | 100% | 1 |
| 4I3X_NAD_B_501 | 95% | 20% | 0.059 | 0.968 | 1.48 | 1.79 | 7 | 12 | 2 | 0 | 100% | 1 |
| 4I3X_NAD_C_501 | 94% | 13% | 0.059 | 0.963 | 1.59 | 2.2 | 7 | 21 | 6 | 0 | 100% | 1 |
| 4I3X_NAD_G_501 | 94% | 19% | 0.062 | 0.966 | 1.33 | 1.97 | 7 | 18 | 4 | 0 | 100% | 1 |
| 4I3X_NAD_D_501 | 92% | 18% | 0.064 | 0.959 | 1.58 | 1.82 | 8 | 16 | 6 | 0 | 100% | 1 |
| 4I3X_NAD_E_501 | 91% | 15% | 0.068 | 0.962 | 1.51 | 2.15 | 9 | 18 | 3 | 0 | 100% | 1 |
| 4I3X_NAD_F_501 | 90% | 18% | 0.07 | 0.959 | 1.53 | 1.87 | 7 | 19 | 4 | 0 | 100% | 1 |
| 4I3X_NAD_H_501 | 87% | 19% | 0.076 | 0.955 | 1.61 | 1.77 | 8 | 13 | 3 | 0 | 100% | 1 |
| 4I3V_NAD_B_501 | 72% | 18% | 0.065 | 0.959 | 1.53 | 1.89 | 5 | 9 | 0 | 0 | 61% | 1 |
| 4I3W_NAD_C_502 | 68% | 19% | 0.083 | 0.93 | 1.44 | 1.92 | 6 | 11 | 1 | 0 | 80% | 1 |
| 1DBV_NAD_O_336 | 100% | 18% | 0.012 | 0.999 | 1.39 | 1.98 | 5 | 12 | 0 | 0 | 100% | 1 |
| 1HZJ_NAD_A_400 | 100% | 22% | 0.009 | 0.999 | 1.43 | 1.7 | 8 | 8 | 1 | 0 | 100% | 1 |
| 1OWB_NAD_A_3000 | 100% | 7% | 0.015 | 0.998 | 2.36 | 2.37 | 10 | 13 | 1 | 0 | 100% | 1 |
| 2NAD_NAD_B_394 | 100% | 7% | 0.016 | 0.997 | 2.25 | 2.54 | 14 | 23 | 3 | 0 | 100% | 1 |
| 2QG4_NAD_F_500 | 100% | 19% | 0.017 | 0.998 | 1.81 | 1.58 | 4 | 9 | 0 | 0 | 100% | 1 |
